CHRONIC TRANSFUSION AND THERAPY FOR REFRACTORY ANEMIAS

难治性贫血的长期输血和治疗

• 批准号: 3763031
• 负责人: PETER A LANE
• 金额: --
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3763031
• 关键词: anemia; blood transfusion; chelating agents; chelation therapy; chemoprevention; deferoxamine; human subject; human therapy evaluation; iron disorder; longitudinal human study; sickle cell anemia

This is a long-term study to determine the efficacy of deferoxamine in the treatment and prophylaxis of iron overload due to chronic transfusion therapy of anemias and sickle cell disease.

这是一项长期研究，以确定去铁胺的疗效， 慢性输血所致铁超载的防治 贫血和镰状细胞病的治疗。